Vaccine(s) were received on 07/22/2016
Vaccine(s) were received in the state: MS
Patient sex : F
Reaction was life threatening?: N
Patient eventually recovered from reaction ?: U
Patient eventually died?: N

The following Data for this patients ALLERGIES is available: [ ]

Description of adverse reaction: Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy on 22-JUL-2016, for routine health maintenance and for the prevention of shingles. The zoster vaccine live did not prevent shingles, but rather caused the patient to contract a persistent strain of herpes zoster. Shortly after receiving the ZOSTAVAX, the patient began to experience feelings of numbness, tingling and joint pain, accompanied by a burning sensation concentrated in her left shoulder and the midsection of her body. In response to these complaints, on 28-OCT-2016, the patient presented to her primary care physician and was diagnosed as suffering from neuropathic pain. The patient's complaints did not improve. Accordingly, the patient was referre

Vaccine(s) associated with report# 755973

Type	Name	Manufacturer	Vaccine LOT #	Dose Series	ROUTE	Site
VARZOS	ZOSTER (ZOSTAVAX)	MERCK & CO. INC.		0	UN

Symptoms(s) associated with report# 755973

Arthralgia
Burning sensation
Herpes zoster
Hypoaesthesia
Neuralgia
Paraesthesia
Small fibre neuropathy